Rockwell Medical, Inc. (RMTI)
| Market Cap | 128.62M |
| Revenue (ttm) | 94.37M |
| Net Income (ttm) | -4.92M |
| Shares Out | 31.03M |
| EPS (ttm) | -0.16 |
| PE Ratio | n/a |
| Forward PE | 118.43 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 824,602 |
| Open | 4.090 |
| Previous Close | 4.020 |
| Day's Range | 4.090 - 4.450 |
| 52-Week Range | 1.160 - 4.450 |
| Beta | 1.47 |
| Analysts | Strong Buy |
| Price Target | 7.00 (+68.88%) |
| Earnings Date | Nov 12, 2024 |
About RMTI
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products,... [Read more]
Financial Performance
In 2023, Rockwell Medical's revenue was $83.61 million, an increase of 14.84% compared to the previous year's $72.81 million. Losses were -$8.59 million, -54.02% less than in 2022.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for RMTI stock is "Strong Buy." The 12-month stock price forecast is $7.0, which is an increase of 68.88% from the latest price.
News
Rockwell Medical Named a Fortune 'Best Workplaces in Manufacturing & Production'
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Great Place to Work and Fortune magazine selected Rockwell Medical for the 2024 Fortune Best Workplaces in Manufacturing and Production ...
Rockwell Medical: The Turnaround Is Looking Real
Rockwell develop concentrates for hemodialysis, which is a process that seeks to artificially replace kidney function in patients with chronic failure. Despite being a critical product, there's curren...
Rockwell Medical Announces Product Purchase Agreement with Leading At-Home and Acute Care Dialysis Provider
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces a product purchase agreement with the leading at-home and acute care dialysis provider in the United States.
Rockwell Medical, Inc. (RMTI) Q2 2024 Earnings Call Transcript
Rockwell Medical, Inc. (RMTI) Q2 2024 Earnings Call Transcript
Rockwell Medical Reports Profitability on a Cash Flow and Adjusted EBITDA Basis in the Second Quarter of 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced financial and operational results for the three and six months ended June 30, 2024.
Rockwell Medical Launches Convenience Pack to Support Home Hemodialysis and Acute Dialysis Facilities
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's Convenience Pack offers a number of advantages for home hemodialysis patients and acute care dialysis facilities.
Rockwell Medical Looks Like A Speculative Buy As It Approaches Profitability
Rockwell is a microcap manufacturer of hemodialysis concentrates for kidney failure patients, trading at under 1x full-year 2023 revenue. The company has a significant market opportunity with the grow...
Rockwell Medical to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's president and CEO, Dr. Mark Strobeck, to present at the H.C. Wainwright 3rd Annual Kidney Conference.
Rockwell Medical to Release Second Quarter 2024 Results on Thursday, August 8, 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the second quarter ended June 30, 2024 on Thursday, August 8, 20...
Rockwell Medical Promotes Tim Chole to Chief Commercial Officer
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Mr. Chole has played a key role in helping Rockwell Medical increase its market share and broaden its product portfolio.
Rockwell Medical, Inc. (RMTI) Q1 2024 Earnings Call Transcript
Rockwell Medical, Inc. (NASDAQ:RMTI) Q1 2024 Earnings Conference Call May 14, 2024 8:00 AM ET Company Participants Heather Hunter - Senior Vice President, Chief Corporate Affairs Officer Mark Strobec...
Rockwell Medical Announces First Quarter 2024 Results, Raises 2024 Guidance
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical (Nasdaq: RMTI) today announced financial and operational results for the three months ended March 31, 2024.
Rockwell Medical Continues to Expand its Distribution Capabilities in Western United States
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical enters into a new direct supply agreement with one of the largest health systems in the Mountain West Region of the Uni...
Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the first quarter ended March 31, 2024 on Tuesday, May 14, 2024.
Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical enters into new and expanded distribution agreements with BioNuclear and Atlantic Medical International, respectively.
Rockwell Medical Named 'Great Place to Work' for Second Year in a Row
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced that it has been certified as a Great Place to Work® for the second year in a row.
Rockwell Medical, Inc. (RMTI) Q4 2023 Earnings Call Transcript
Rockwell Medical, Inc. (RMTI) Q4 2023 Earnings Call Transcript
Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes...
Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the fourth quarter and full-year ended December 31, 2023 on Thursday, March 21, 2024.
Rockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Defers principal payments of $8M up to 3yrs, reduces Rockwell Medical's need for additional operating capital, and enhances the Company'...
Returning To Rockwell Medical: Buy At 65% Of Revenue
Rockwell Medical is arguably the strongest player in the hemodialysis market and a top 5 healthcare supplier per Seeking Alpha Quant. The Company still addresses a critical medical condition and has a...
Rockwell Medical, Inc. (RMTI) Q3 2023 Earnings Call Transcript
Rockwell Medical, Inc. (NASDAQ:RMTI) Q3 2023 Earnings Conference Call November 14, 2023 8:00 AM ET Company Participants Heather Hunter - SVP & Chief Corporate Affairs Officer Mark Strobeck - Presiden...
Rockwell Medical Announces Third Quarter 2023 Results
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes...
Rockwell Medical Names Jesse Neri as Senior Vice President, Finance
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Jesse Neri has 20+ years' experience leading finance functions at both public and private companies.
Rockwell Medical Appoints Joan Lau, Ph.D. to the Company's Board of Directors
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Dr. Joan Lau brings 20+ years of experience as an entrepreneur scientist, CEO, operator, investor, and board member of public and privat...